albuterol.Bronchodilators should not be the only or main treatment in patients with severe or unstable asthma. Severe asthma requires regular medical assessment including lung function testing as patients are at risk of severe attacks and even death. Physicians should consider using oral corticosteroid therapy and/or the maximum recommended dose of inhaled corticosteroid in those patients.
Patients should seek medical advice if treatment with salbutamol tablets becomes less effective. The dosage or frequency of administration should only be increased on medical advice.
Patients taking salbutamol tablets may also be receiving short-acting inhaled bronchodilators to relieve symptoms.
The management of asthma should normally follow a stepwise programme, and patient response should be monitored clinically and by lung function tests.
Increasing use of bronchodilators in particular short-acting inhaled beta2-agonists to relieve symptoms indicates deterioration of asthma control. The patient should be instructed to seek medical advice if short acting relief bronchodilator treatment becomes less effective or they need more inhalations than usual.
In this situation patients should be reassessed and consideration given to the need for increased anti-inflammatory therapy (e.g. higher doses of inhaled corticosteroids or a course of oral corticosteroid). Severe exacerbations of asthma must be treated in the normal way.
Patients should be warned that if either the usual relief with salbutamol tablets is diminished or the usual duration of action reduced, they should not increase the dose or its frequency of administration, but should seek medical advice.
Cardiovascular effects may be seen with sympathomimetic drugs, including salbutamol. There is some evidence from post-marketing data and published literature of rare occurrences of myocardial ischaemia associated with salbutamol. Patients with underlying severe heart disease (e.g. ischaemic heart disease, arrhythmia or severe heart failure) who are receiving salbutamol should be warned to seek medical advice if they experience chest pain or other symptoms of worsening heart disease. Attention should be paid to assessment of symptoms such as dyspnoea and chest pain, as they may be of either respiratory or cardiac origin. albuterol
Salbutamol should be administered cautiously to patients suffering from thyrotoxicosis. albuterol
Potentially serious hypokalaemia may result from beta-2 agonist therapy mainly from parenteral and nebulized administration. Particular caution is advised in acute severe asthma as this effect may be potentiated by hypoxia and by concomitant treatment with xanthine derivatives, steroids and diuretics. It is recommended that serum potassium levels are monitored in such situations.
In common with other β-adrenoceptor agonists, salbutamol can induce reversible metabolic changes such as increased blood glucose levels. Diabetic patients may be unable to compensate for the increase in blood glucose and the development of ketoacidosis has been reported. Concurrent administration of corticosteroids can exaggerate this effect.
Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose – galactose malabsorption should not take this medicine.
Salbutamol tablets contain carmoisine (E122) which may cause allergic reactions.
This medicine contains less than 1 mmol sodium (23mg) per tablet, that is to say essentially ‘sodium-free’.
Salbutamol tablets and non-selective beta-blocking drugs, such as propranolol, should not usually be prescribed together.
The effects of salbutamol may be altered by tricyclic antidepressants (e.g. clomipramine) and monoamine oxidase inhibitors (e.g. rasagiline, selegiline, isocarboxazid, phenelzine, tranylcypromine).
Potassium depleting agents
Owing to the hypokalaemic effect of beta-agonists, concurrent administration of serum potassium
depleting agents known to exacerbate the risk of hypokalaemia, such as diuretics (e.g. bendroflumethiazide, indapamide, bumetanide, furosemide), digoxin, methyl xanthines (e.g. aminophylline, theophylline) and corticosteroids (e.g. betamethasone, prednisolone, triamcinolone), should be administered cautiously after careful evaluation of the benefits and risks with special regard to the increased risk of cardiac arrhythmias arising as a result of hypokalaemia (see section 4.4).
There is an increased risk of hypokalaemia if high doses of theophylline or high doses of corticosteroids are given with higher doses of salbutamol.
Administration of drugs during pregnancy should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus.
As with the majority of drugs, there is little published evidence of its safety in the early stages of human pregnancy, but in animal studies there was evidence of some harmful effects on the foetus at very high dose levels.
As salbutamol is probably secreted in breast milk its use in nursing mothers requires careful consideration.
It is not known whether salbutamol has a harmful effect on the neonate, and so its use should be restricted to situations where it is felt that the expected benefit to the mother is likely to outweigh any potential risk to the neonate.
There is no information on the effects of salbutamol on human fertility. There were no adverse effects on fertility in animals (see section 5.3).
The frequencies of adverse reactions are ranked according to the following MedDRA convention: Common (≥1/100 to <1/10); Uncommon (≥1/1,000 to <1/100); Rare (≥1/10,000 to <1/1,000); Very rare (<1/10,000); Not known (cannot be estimated from the available data).
BUY SALBUTAMOL 2MG
Bodybuilders Buying Salbutamol 2mg, I also know it under the name Albuterol. Salbutamol is marketed as Ventolin and is a drug, which opens the middle and large airways in the lungs. It is used to treat asthma including asthma attacks, exercise-induced bronchoconstriction and chronic obstructive pulmonary disease (COPD) applied.
Salbutamol 2mg is a sympathomimetic, which is used as a bronchospasmolytic in bronchial asthma and chronic bronchitis with or without emphysema.
INGESTION AND DOSAGE
Salbutamol 2mg can also be used, to treat high levels of potassium in the blood. Salbutamol is usually used with an inhaler or nebulizer, however, it is also available as a pill and intravenous solution. The onset of action of the inhaled version is usually within 15 Minutes and takes two to six hours.
Salbutamol causes, administered by inhalation, a rapid onset and long-lasting relaxation of the smooth muscles in the bronchi.
SALBUTAMOL 2MG SIDE EFFECTS albuterol
Common Salbutamol 2mg side effects include jiggling, a headache, fast heartbeat, Dizziness and anxiety. One of the more serious side effects may be worsening bronchospasm, irregular heartbeat and low blood potassium levels.